About: http://webisa.webdatacommons.org/130254676

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	August 26 ??? Galectin Therapeutics, focusing on diseases such as fatty liver disease where galectin proteins play a major role in the disease process, has developed 2 classes of galectin inhibitors.
http://www.w3.org/ns/prov#wasQuotedFrom	hepb.org